Assessing weight change of risperidone long - acting injectable treatment in dual diagnosis patients

被引：0
作者：
Natan, Z. [1 ]
Gimelfarb, Y. [1 ]
Kaikov, E. [1 ]
机构：
[1] Abarbanel Mental Hlth Ctr, Bat Yam, Israel
来源：
EUROPEAN PSYCHIATRY | 2008年 / 23卷
关键词：
D O I：
10.1016/j.eurpsy.2008.01.953
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
引用
收藏
页码：S165 / S165
页数：1
相关论文
共 50 条
  • [31] Risperidone Long-Acting Injectable Monotherapy in the Maintenance Treatment of Bipolar I Disorder
    Quiroz, Jorge A.
    Yatham, Lakshmi N.
    Palumbo, Joseph M.
    Karcher, Keith
    Kushner, Stuart
    Kusumakar, Vivek
    BIOLOGICAL PSYCHIATRY, 2010, 68 (02) : 156 - 162
  • [32] Schizoaffective disorders:: Significant improvements following therapy change to risperidone long-acting injectable
    Mohl, A
    Westly, K
    Opjordsmoen, S
    Lex, A
    Bräunig, P
    EUROPEAN PSYCHIATRY, 2005, 20 : S79 - S80
  • [33] Health-related quality of life in patients with schizophrenia during treatment with long-acting, injectable risperidone
    Nasrallah, HA
    Duchesne, I
    Mehnert, A
    Janagap, C
    Eerdekens, M
    JOURNAL OF CLINICAL PSYCHIATRY, 2004, 65 (04) : 531 - 536
  • [34] EFFECTIVENESS OF LONG-ACTING INJECTABLE RISPERIDONE IN THE POST-ACUTE TREATMENT OF SCHIZOPHRENIC PATIENTS IN AMBULATORY CARE
    Hargarter, L.
    Diekamp, B.
    Ibach, B.
    Juckel, G.
    EUROPEAN PSYCHIATRY, 2010, 25
  • [35] Improved outcome in psychotic patients treated with risperidone long acting injectable: Experience in German patients
    Moeller, H
    Schreiner, A
    Kissling, W
    Naber, D
    Schmauss, M
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2004, 7 : S236 - S236
  • [36] Impact of risperidone long-acting injectable on hospitalization and medication use in patients with schizophrenia
    Beauclair, L.
    Lam, A.
    McCormick, J.
    Luong, D.
    Camacho, F.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2006, 9 : S263 - S263
  • [37] Efficacy and safety of risperidone long-acting injectable in stable psychotic patients previously treated with oral risperidone
    Schmauss, Max
    Sacchetti, Emilio
    Kahn, Jean-Pierre
    Medori, Rossella
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2007, 22 (02) : 85 - 92
  • [38] Improved efficacy and safety in Danish patients treated with risperidone long-acting injectable
    Glue, P
    Lublin, H
    Refshammer, C
    Lex, A
    Lang-Jensen, L
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2004, 7 : S402 - S403
  • [39] Risperidone long-acting injectable in elderly psychotic patients: assessment of tolerability and efficacy
    Simpson, S
    Heise, M
    Kontis, K
    Glue, P
    Medori, R
    Kissling, W
    INTERNATIONAL PSYCHOGERIATRICS, 2005, 17 : 364 - 364
  • [40] Obese patients with schizophrenia and schizoaffective disorder: Efficacy of injectable long-acting risperidone
    Permuy, RT
    Turner, MS
    Bouhours, P
    SCHIZOPHRENIA RESEARCH, 2004, 67 (01) : 175 - 175
12345